Trial Profile
A phase II study about interferon gamma 1b to therapy the steroid-refractory bronchiolitis obliterans after allogenic stem cell therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Apr 2015
Price :
$35
*
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Bronchiolitis obliterans
- Focus Therapeutic Use
- 11 Apr 2015 Status changed from active, no longer recruiting to completed as reported by EudraCT record.
- 13 Aug 2012 New trial record